Fuller & Thaler Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-63,856
| Closed | -$10.9M | – | 560 |
|
|
2020
Q4 | $10.9M | Buy |
63,856
+1,272
| +2% | +$217K | 0.1% | 191 |
|
|
2020
Q3 | $8.79M | Sell |
62,584
-46,386
| -43% | -$6.51M | 0.11% | 183 |
|
|
2020
Q2 | $17.5M | Buy |
108,970
+1,066
| +1% | +$171K | 0.23% | 117 |
|
|
2020
Q1 | $10.6M | Sell |
107,904
-2,413
| -2% | -$236K | 0.18% | 128 |
|
|
2019
Q4 | $14.2M | Sell |
110,317
-1,739
| -2% | -$224K | 0.16% | 143 |
|
|
2019
Q3 | $8.44M | Sell |
112,056
-202
| -0.2% | -$15.2K | 0.1% | 170 |
|
|
2019
Q2 | $17.1M | Buy |
112,258
+306
| +0.3% | +$46.5K | 0.2% | 126 |
|
|
2019
Q1 | $13.3M | Sell |
111,952
-20,815
| -16% | -$2.48M | 0.17% | 126 |
|
|
2018
Q4 | $14.5M | Sell |
132,767
-4,718
| -3% | -$515K | 0.21% | 112 |
|
|
2018
Q3 | $22.2M | Sell |
137,485
-8,369
| -6% | -$1.35M | 0.23% | 115 |
|
|
2018
Q2 | $19.3M | Buy |
145,854
+709
| +0.5% | +$93.7K | 0.21% | 108 |
|
|
2018
Q1 | $10.8M | Sell |
145,145
-5,005
| -3% | -$371K | 0.13% | 131 |
|
|
2017
Q4 | $8.35M | Buy |
+150,150
| New | +$8.35M | 0.1% | 143 |
|